Dr Paul MacLeman resigns
The Managing Director of IDT, Dr Paul MacLeman has resigned from the position, to advance new business initiatives and to pursue further non‐executive board roles. His resignation as CEO will take effect from 31st August 2017. Dr MacLeman will resign from the Board as at close of business today.
The Chairman, Mr Graeme Kaufman, thanked Paul for his contribution to the development of IDT, noting “With his strong background in corporate strategy, Paul correctly identified the limited growth opportunities in IDT’s traditional markets and the need to capture more of the value chain, leading to the development of our generics business. We will miss him, and wish him well in his future endeavours.”